Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 176 to 200 of about 5901

Previous 25

Website Changes

02/27/2024

Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress

02/27/2024

Impact of Reirradiation Utilizing Fractionated Stereotactic Radiotherapy for Recurrent Glioblastoma

02/25/2024

Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to Sonodynamic Therapy (SDT)

02/25/2024

Promising Pathway Act Open House in Washington, DC This Tuesday!

02/24/2024

Biodexa Reports Positive Phase 1 Trial Results For Diffuse Midline Glioma

02/23/2024

Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro

02/23/2024

New GT Medical CEO Per Langoe on driving adoption of brain tumor therapy

02/21/2024

Promising Pathway Act Open House in Washington, DC This Tuesday!

02/21/2024

Sonodynamic Therapy Webinar added to website!

02/20/2024

`Olive oil` drug shows promise in treating aggressive brain cancer at London hospital

02/20/2024

FDA and EMA Accept Vorasidenib Regulatory Submissions for the Treatment of IDH-mutant diffuse glioma

02/20/2024

Webinar on Sonodynamic Therapy For Brain Tumors this Wednesday 2/21/24!

02/19/2024

OurBrainBank Launches Nationwide Survey to Address Healthcare Disparities in Glioblastoma Care

02/14/2024

IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology

02/11/2024

OurBrainBank Launches Nationwide Survey to Address Healthcare Disparities in Glioblastoma Care

02/09/2024

Brain cancer a thing of the past?

02/08/2024

Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients

02/07/2024

Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma

02/06/2024

Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification

02/03/2024

Copayment Assistance Program update!

02/02/2024

Biomarker Testing for Brain Cancer!

02/02/2024

Australian government steps in to fund experimental brain cancer drug

02/02/2024

TME Pharma Announces Final Median Overall Survival Data Reaching 19.9 Months for NOX-A12 Combination Regimen in GLORIA Brain Cancer Trial and Survival Rate 10-Fold Greater Than Standard of Care

02/02/2024

Biomarker Testing for Brain Cancer!

02/02/2024

Press Release IB awarded a $100,000 grant by the Musella Foundation

Our privacy / cookie policy has changed.
Click HERE to read it!